Skip to main content
SpringerLink
Log in

Reduction in NGAL at 48 h predicts the progression to CKD in patients with septic associated AKI: a single-center clinical study

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

In this study, our objective was to investigate the predictive value of serum and urine fluctuations of neutrophil gelatinase-associated lipid transporters (NGAL) in relation to the progression of chronic kidney disease (CKD) among patients with septic associated AKI (SA-AKI).

Methods

A total of 425 SA-AKI patients were enrolled in this study and divided into the recovery group (n = 320) and the AKI-to-CKD group (n = 105) based on 3-month follow-up data. The serum and urine NGAL levels on the day of AKI diagnosis (T0) and 48 h after anti-AKI treatment (T1) were recorded and calculated.

Results

The levels of NGAL in serum and urine were found to be higher in the AKI-to-CKD group compared to the recovery group at T1 point (P < 0.05). The reductions of NGAL at 48 h in serum and urine were lower in the AKI-to-CKD group than those observed in the recovery group (P < 0.05). In comparison to T0, a significant decrease was noted for both serum and urine NGAL levels on T1 among patients who recovered from AKI (P < 0.05), whereas no such trend was observed among those with AKI-to-CKD transition (P > 0.05). After adjusting age, sex, and BMI through partial correlation analysis, the reduction of serum NGAL was found to be most strongly associated with the transition from AKI to CKD. ROC analysis showed an AUC of 0.832 for serum NGAL reduction, with a cut-off value of − 111.24 ng/ml and sensitivity and rates of 76.2% and 81.2%, respectively. Logistic regression analysis indicated that a reduction of serum NGAL ≥ − 111.24 ng/ml was the early warning indicator for the progression of CKD in SA-AKI patients.

Conclusion

The reduction of serum NGAL following 48 h of anti-AKI therapy represents a distinct hazard factor for the advancement of CKD in patients with SA-AKI, independent of other variables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

References

  1. Sun J, Zhang J, Tian J, Virzi GM, Digvijay K, Cueto L et al (2019) Mitochondria in sepsis-induced AKI. J Am Soc Nephrol 30(7):1151–1161. https://doi.org/10.1681/ASN.2018111126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. He FF, Wang YM, Chen YY, Huang W, Li ZQ, Zhang C (2022) Sepsis-induced AKI: from pathogenesis to therapeutic approaches. Front Pharmacol 13:981578. https://doi.org/10.3389/fphar.2022.981578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kuwabara S, Goggins E, Okusa MD (2022) The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol 17(7):1050–1069. https://doi.org/10.2215/CJN.00850122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Horrillo AS, Villanueva LS, Cardenas AC, Ramos PM, Ortiz A, Quiroga B (2022) Infectious consequences of the AKI-to-CKD transition. Clin Kidney J 15(12):2237–2244. https://doi.org/10.1093/ckj/sfac178

    Article  PubMed  Google Scholar 

  5. Wang Z, Zhang C (2022) From AKI to CKD: maladaptive repair and the underlying mechanisms. Int J Mol Sci. https://doi.org/10.3390/ijms231810880

    Article  PubMed  PubMed Central  Google Scholar 

  6. Li C, Wang W, Xie SS, Ma WX, Fan QW, Chen Y et al (2021) The programmed cell death of macrophages, endothelial cells, and tubular epithelial cells in sepsis-AKI. Front Med (Lausanne). 8:796724. https://doi.org/10.3389/fmed.2021.796724

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shang W, Wang Z (2017) The Update of NGAL in Acute Kidney Injury. Curr Protein Pept Sci 18(12):1211–1217. https://doi.org/10.2174/1389203717666160909125004

    Article  CAS  PubMed  Google Scholar 

  8. Nga HS, Medeiros P, Menezes P, Bridi R, Balbi A, Ponce D (2015) Sepsis and AKI in clinical emergency room patients: the role of urinary NGAL. Biomed Res Int. https://doi.org/10.1155/2015/413751

    Article  PubMed  Google Scholar 

  9. Lentini P, de Cal M, Clementi A, D’Angelo A, Ronco C (2012) Sepsis and AKI in ICU patients: the role of plasma biomarkers. Crit Care Res Pract. https://doi.org/10.1155/2012/856401

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhang L, Xu F, Han D, Huang T, Li S, Yin H et al (2021) Influence of the trajectory of the urine output for 24 h on the occurrence of AKI in patients with sepsis in intensive care unit. J Transl Med 19(1):518. https://doi.org/10.1186/s12967-021-03190-w

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C et al (2010) Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 298(6):F1472–F1483. https://doi.org/10.1152/ajprenal.00619.2009

    Article  CAS  PubMed  Google Scholar 

  12. Dong Y, Zhang Q, Wen J, Chen T, He L, Wang Y et al (2019) Ischemic duration and frequency determines AKI-to-CKD progression monitored by dynamic changes of tubular biomarkers in IRI mice. Front Physiol 10:153. https://doi.org/10.3389/fphys.2019.00153

    Article  PubMed  PubMed Central  Google Scholar 

  13. Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85(1):49–61. https://doi.org/10.1038/ki.2013.444

    Article  PubMed  Google Scholar 

  14. Pajulammi HM, Luukkaala TH, Pihlajamaki HK, Nuotio MS (2016) Decreased glomerular filtration rate estimated by 2009 CKD-EPI equation predicts mortality in older hip fracture population. Injury 47(7):1536–1542. https://doi.org/10.1016/j.injury.2016.04.028

    Article  PubMed  Google Scholar 

  15. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810. https://doi.org/10.1001/jama.2016.0287

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Andrassy KM (2013) Comments on “KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.” Kidney Int 84(3):622–623. https://doi.org/10.1038/ki.2013.243

    Article  CAS  PubMed  Google Scholar 

  17. Genga KR, Trinder M, Kong HJ, Li X, Leung AKK, Shimada T et al (2018) CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis. Sci Rep 8(1):16764. https://doi.org/10.1038/s41598-018-35261-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Walls AB, Bengaard AK, Iversen E, Nguyen CN, Kallemose T, Juul-Larsen HG et al (2021) Utility of suPAR and NGAL for AKI risk stratification and early optimization of renal risk medications among older patients in the emergency department. Pharmaceuticals (Basel). https://doi.org/10.3390/ph14090843

    Article  PubMed  Google Scholar 

  19. Sharrod-Cole H, Fenn J, Gama R, Ford C, Giri R, Luckraz H (2022) Utility of plasma NGAL for the diagnosis of AKI following cardiac surgery requiring cardiopulmonary bypass: a systematic review and meta-analysis. Sci Rep 12(1):6436. https://doi.org/10.1038/s41598-022-10477-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zhao ZB, Marschner JA, Iwakura T, Li C, Motrapu M, Kuang M et al (2023) Tubular epithelial cell HMGB1 promotes AKI-CKD transition by sensitizing cycling tubular cells to oxidative stress: a rationale for targeting HMGB1 during AKI recovery. J Am Soc Nephrol 34(3):394–411. https://doi.org/10.1681/ASN.0000000000000024

    Article  PubMed  Google Scholar 

  21. Arshad A, Ayaz A, Rehman S, Ukrani RD, Akbar I, Jamil B (2021) Progression of acute kidney injury to chronic kidney disease in sepsis survivors: 1-year follow-up study. J Intensive Care Med 36(11):1366–1370. https://doi.org/10.1177/0885066620956621

    Article  PubMed  Google Scholar 

  22. Heung M, Steffick DE, Zivin K, Gillespie BW, Banerjee T, Hsu CY et al (2016) Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data. Am J Kidney Dis 67(5):742–752. https://doi.org/10.1053/j.ajkd.2015.10.019

    Article  PubMed  Google Scholar 

  23. Tuan PNH, Quyen DBQ, Van Khoa H, Loc ND, Van My P, Dung NH et al (2020) Serum and urine neutrophil gelatinase-associated lipocalin levels measured at admission predict progression to chronic kidney disease in sepsis-associated acute kidney injury patients. Dis Markers 2020:8883404. https://doi.org/10.1155/2020/8883404

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Devarajan P (2008) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89–94. https://doi.org/10.1080/00365510802150158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sinna MM, Altaf FMN, Mosa OF (2019) Serum and urinary NGAL and cystatin C levels as diagnostic tools for acute kidney injury and chronic kidney disease: a histobiochemical comparative study. Curr Pharm Des 25(10):1122–1133. https://doi.org/10.2174/1381612825666190516080920

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank all of the participants for their time and effort.

Funding

The subject of Yangzhou University affiliated Hospital (2017120406).

Author information

Authors and Affiliations

  1. Department of Medical Laboratory, Yangzhou University Affiliated Hospital, Yangzhou, Jiangsu, China

    Zhang Ya-fen, Chen Jing & Ding Chang-ping

  2. Department of Emergence, Yangzhou University Affiliated Hospital, Yangzhou, Jiangsu, China

    Zhang Yue-fei

Authors
  1. Zhang Ya-fen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chen Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhang Yue-fei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ding Chang-ping
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DCP and ZYF conceived the research. ZYF, CJ and ZYF collected and analyzed the clinical data. ZYF designed the study. ZYF drafted the manuscript. ZYF and DCP reviewed the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ding Chang-ping.

Ethics declarations

Conflict of interest

No potential conflict of interest was reported by the author(s).

Ethics approval and consent to participate

Clinical Research Ethics Committee of Yangzhou university affiliated hospital approved this study (2022-YKL1-20-008). All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ya-fen, Z., Jing, C., Yue-fei, Z. et al. Reduction in NGAL at 48 h predicts the progression to CKD in patients with septic associated AKI: a single-center clinical study. Int Urol Nephrol 56, 607–613 (2024). https://doi.org/10.1007/s11255-023-03689-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03689-9

Keywords

Search

Navigation